Duovir-N - Lamivudine , Zidovudine & Nevirapine 650 mg Tabs

This fixed-dose combination brings together two nucleoside reverse transcriptase inhibitors (NRTIs), Lamivudine and Zidovudine, along with a non-nucleoside reverse transcriptase inhibitor (NNRTI), Nevirapine, offering a complete highly active antiretroviral therapy (HAART) regimen in a single tablet. By acting on HIV replication through two different mechanisms, this combination helps more effectively lower viral load and reduce the likelihood of drug resistance developing. As the virus is suppressed, the immune system is given the opportunity to recover, often reflected in improved CD4 cell counts over time. This all-in-one formulation can make treatment more convenient for patients, supporting better adherence to a consistent dosing schedule, which is essential for long-term success. It is typically taken orally, following a schedule set by a healthcare provider based on the patient's individual needs. Regular monitoring, including blood tests for viral load, CD4 counts, and liver function, is generally recommended throughout treatment. Many patients using this combination achieve strong, sustained viral suppression and meaningful improvements in overall immune health. As with all antiretroviral therapies, it should be used under the close supervision of a healthcare provider as part of a comprehensive, personalized HIV care plan.